Detalles de la búsqueda
1.
Forget lung, breast or prostate cancer: why tumour naming needs to change.
Nature;
626(7997): 26-29, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347121
2.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat;
199(2): 371-379, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988749
3.
Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
Gynecol Oncol;
168: 32-38, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370612
4.
Antibody-Drug Conjugate Revolution in Breast Cancer: The Road Ahead.
Curr Treat Options Oncol;
24(5): 442-465, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966267
5.
From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
Int J Mol Sci;
24(6)2023 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36982662
6.
Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities.
Int J Mol Sci;
24(17)2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686020
7.
Exosomes in the Diagnosis and Treatment of Renal Cell Cancer.
Int J Mol Sci;
24(18)2023 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762660
8.
Changing the landscape of European School of Oncology-European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic.
Future Oncol;
18(25): 2857-2864, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722882
9.
Learning by Debate: Innovative Tool in the Hematology-Oncology Fellowship Program.
J Cancer Educ;
37(6): 1641-1644, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33788148
10.
Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of Oncology.
J Cancer Educ;
37(1): 231-236, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34655420
11.
The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian Regions.
J Cancer Educ;
37(1): 224-229, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34292502
12.
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
Br J Cancer;
125(11): 1486-1493, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34588616
13.
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.
Oncologist;
26(5): 389-396, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33554383
14.
Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primary.
Eur J Clin Invest;
51(9): e13583, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33970501
15.
Educational contribution of the College of the European School of Oncology to the Latin American Oncologists.
Future Oncol;
17(23): 2981-2987, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098727
16.
The management of patients with cancer of unknown primary in middle-income countries: an ESO-AROME survey.
Future Oncol;
17(2): 151-157, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33305604
17.
Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets.
Int J Mol Sci;
22(18)2021 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34576107
18.
Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.
Int J Cancer;
146(6): 1490-1498, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144291
19.
Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?
Br J Cancer;
122(8): 1124-1132, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32042068
20.
Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach.
Invest New Drugs;
38(1): 181-193, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650446